SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-009821
Filing Date
2020-05-07
Accepted
2020-05-07 16:11:50
Documents
96
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20200331_10q.htm 10-Q 1338788
2 EXHIBIT 10.28 ex_185106.htm EX-10.28 107585
3 EXHIBIT 31.1 ex_183807.htm EX-31.1 8631
4 EXHIBIT 31.2 ex_183808.htm EX-31.2 8873
5 EXHIBIT 32.1 ex_183809.htm EX-32.1 4394
6 EXHIBIT 32.2 ex_183810.htm EX-32.2 4457
13 logo1.jpg GRAPHIC 3996
14 sig1.jpg GRAPHIC 3535
15 sig2.jpg GRAPHIC 5297
  Complete submission text file 0001437749-20-009821.txt   8756661

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nby-20200331.xml EX-101.INS 1869891
8 XBRL TAXONOMY EXTENSION SCHEMA nby-20200331.xsd EX-101.SCH 105804
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20200331_cal.xml EX-101.CAL 50275
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20200331_def.xml EX-101.DEF 635750
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20200331_lab.xml EX-101.LAB 540627
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20200331_pre.xml EX-101.PRE 673772
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 20856479
SIC: 2834 Pharmaceutical Preparations